CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The RAINBO umbrella program consists of four clinical trials investigating new adjuvant therapies in endometrial cancer patients. E ...
Phase 2, Phase 3
London, United Kingdom and 13 other locations
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
London, London, City Of, United Kingdom and 242 other locations
study to evaluate the efficacy and safety of dostarlimab versus carboplatin-paclitaxel in patients with MMR deficient relapse or advanced endometrial...
Phase 3
London, United Kingdom and 94 other locations
DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...
Phase 3
London, United Kingdom and 237 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
London, United Kingdom and 168 other locations
The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer...
Phase 3
London, United Kingdom and 170 other locations
The purpose of this study is to characterize the safety and tolerability of ALTA2618 in adults with AKT1 E17K-mutant advanced solid tumors....
Phase 1
London, United Kingdom and 45 other locations
This research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer...
Phase 1, Phase 2
London, United Kingdom and 58 other locations
durvalumab (MEDI4736) in patients with relapsed gynaecological cancers to assess the response in groups of patients selected based on their ...
Phase 2
London, United Kingdom and 8 other locations
This is a proof-of-concept study designed to investigate HER3-DXd monotherapy in locally advanced unresectable or metastatic solid tumors. T ...
Phase 2
London, United Kingdom and 74 other locations
Clinical trials
Research sites
Resources
Legal